The text “30N” of the third entry under the column heading “Protease inhibitor-SDRM” in Table 1 of this paper [1] should be emboldened.
Reference
1. Winand R, Theys K, Eusébio M, Aerts J, Camacho RJ, Gomes P, et al.
Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals.
AIDS 2015; 29:2045–2052.
